Navigation Links
Indevus Announces Allergan as New Partner for SANCTURA Brand
Date:9/19/2007

p>

Except for the descriptions of historical facts contained herein, this press release contains forward-looking statements that involve risks and uncertainties that could cause the Company's actual results and financial condition to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties are set forth in the Company's filings under the Securities Act of 1933 and the Securities Exchange Act of 1934 under "Risk Factors" and elsewhere, and include, but are not limited to: dependence on the success of SANCTURA(R), SANCTURA(R) XR, NEBIDO(R), VANTAS(R) and SUPPRELIN(R) LA; the early state of products under development; uncertainties relating to clinical trials, regulatory approval and commercialization of our products, particularly SANCTURA XR, NEBIDO, and VALSTAR(R); risks associated with contractual agreements, particularly for the manufacture and co-promotion of SANCTURA and SANCTURA XR and the manufacture of NEBIDO, VANTAS, SUPPRELIN LA and VALSTAR; dependence on third parties for supplies, particularly for histrelin, manufacturing, marketing, and clinical trials; competition; need for additional funds and corporate partners, including for the development of our products; failure to acquire and develop additional product candidates; changes in reimbursement policies and/or rates for SANCTURA, VANTAS, SUPPRELIN LA, DELATESTRYL(R) and any future products; history of operating losses and expectation of future losses; product liability and insurance uncertainties; risks relating to the Redux- related litigation; the risk that the businesses of Indevus and Valera Pharmaceuticals, Inc. will not be integrated successfully during the period following the related merger; the risk that the cost savings and any other synergies from the merger may not be fully realized or may take longer to realize than expected; market acceptance for the merger and approved products; risks of regulatory review and clinical trials; disruption f
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... , July 21, 2014  Mike Patterson, ... of $1.6 million in Series Seed B funding ... chemical sensors for the life science, defense, intelligence, ... Capital Partners led the round and was joined ... Angels.  Said Patterson , "This round of ...
(Date:7/20/2014)... recycled, the process releases radioactive krypton and xenon gases. ... related gas radon. A new porous material called CC3 ... in Nature Materials shows how: by breathing ... , The CC3 material could be helpful in ... or air in buildings and also in recycling useful ...
(Date:7/18/2014)... -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it ... results on Tuesday, August 5, 2014, before the U.S. ... call and simultaneous webcast at 8:30 AM Eastern Time ... this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 ... from the ,Events and Presentations, page of Regeneron,s website ...
(Date:7/18/2014)... neutral. That is, most of the atoms in ... electrons in the outer parts of atoms equals the ... As one or more electrons are plucked away from ... positive pull from the nucleus. This enhanced pull, ... those electrons are less vulnerable to the distractions of ...
Breaking Biology Technology:Global Graphene Manufacturing Leader, Graphene Frontiers, Receives Series Seed B Funding To Assure Production Of The Next Generation Of Biological And Chemical Sensor Technology 2A noble gas cage 2A noble gas cage 3Highly charged ions 2Highly charged ions 3Highly charged ions 4
... - A new technique inspired by elegant pop-up books ... to be mass-produced by the sheet. Devised by ... enables the rapid fabrication of not just microrobots, but ... 18 layers of carbon fiber, Kapton (a plastic film), ...
... Healthcare organizations are becoming more efficient and effective ... more connected patient care environment. But to have this ... the electronic medical record (EMR) and enterprise content management ... leader in ECM for healthcare , has a ...
... A protein that has shown early promise in preventing the ... has been found in a new study to be a key ... protein biglycan needs to be present to stabilize synapses at the ... Brown University that appears in the Feb. 14, 2012, issue of ...
Cached Biology Technology:In new mass-production technique, robotic insects spring to life 2In new mass-production technique, robotic insects spring to life 3Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System 2Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System 3When nerve meets muscle, biglycan seals the deal 2
(Date:7/22/2014)... researchers in modifying properties of nanomaterials for application in ... to recent innovative studies conducted by scientists from the ... of a simple, efficient and low cost technique involving ... by Professor Sow Chorng Haur from the Department of ... the properties of two different types of materials can ...
(Date:7/22/2014)... Stem cells offer much promise for treating damaged organs ... survival is poor, limiting their effectiveness. New methods are ... optimize their therapeutic function after transplantation, as described in ... a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. ... Open Access website . , In ...
(Date:7/22/2014)... DURHAM, N.C. In a cost-effectiveness analysis of commercial ... the drug Qsymia showed the best value for the ... loss, but was also the most expensive option tested, ... Graduate Medical School. , The findings, published in the ... important information on the health and weight-loss benefits per ...
Breaking Biology News(10 mins):NUS scientists use low cost technique to improve properties and functions of nanomaterials 2NUS scientists use low cost technique to improve properties and functions of nanomaterials 3Study compares cost-effectiveness of weight-loss programs and drugs 2Study compares cost-effectiveness of weight-loss programs and drugs 3
... to save Australia’s iconic Tasmanian devils from the deadly ... Livestock Industries’ Australian Animal Health Laboratory (AAHL), Textiles and ... to hunt down the cause of Devil Facial Tumour ... infected animals. , DFTD is infectious and ...
... markers in the DNA of people with and ... researchers to identify a common gene that appears ... disease. The finding, announced today by researchers at ... Institute, Kronos Science Laboratory and their collaborative partners, ...
... dioxide emissions, but scientists at UC Irvine have determined ... explain one-third or more of the Arctic warming primarily ... soot from tailpipes, smoke stacks and forest fires enters ... is darker than natural snow. Dark surfaces absorb sunlight ...
Cached Biology News:CSIRO scientists join fight to save 'Tassie devil' 2Research team identifies new Alzheimer's gene 2Research team identifies new Alzheimer's gene 3Dirty snow may warm Arctic as much as greenhouse gases 2
... that made the original Gene Pulser apparatus and ... has been applied in the Gene Pulser II ... design of the Gene Pulser II system has ... has the widest range of settings to target ...
Experion Pro260 chips are the microfluidic chips used to perform protein analysis with the Experion automated electrophoresis system. Each chip has the capacity to run 10 protein samples. Supplied as...
... Experion Pro260 reagents and supplies, ... and supplies sufficient to perform protein ... Experion automated electrophoresis system. Supplied are ... 45 microliters Pro260 stain, 60 microliters ...
... 3000 drug discovery system miniaturizes, integrates ... Using LabChip technology, the LabChip ... serial, continuous flow fashion. LabChip assays ... results exceeds what is achievable in ...
Biology Products: